
Circulating Tumor Cell Market by Specimen (Blood, Bone Marrow), Technology (CTC Analysis, CTC Detection & Enrichment Methods, CTC Direct Detection Methods), Product, Application - Global Forecast 2024-2030
Description
Circulating Tumor Cell Market by Specimen (Blood, Bone Marrow), Technology (CTC Analysis, CTC Detection & Enrichment Methods, CTC Direct Detection Methods), Product, Application - Global Forecast 2024-2030
The Circulating Tumor Cell Market size was estimated at USD 12.44 billion in 2023 and expected to reach USD 14.17 billion in 2024, at a CAGR 13.99% to reach USD 31.12 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Circulating Tumor Cell Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Circulating Tumor Cell Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Circulating Tumor Cell Market, highlighting leading vendors and their innovative profiles. These include BioFluidica, Biolidics Limited, Creatv MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., IVDiagnostics, LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec GmbH, NanoString Technologies, Inc., Precision Medicine Group, LLC, QIAGEN GmbH, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, and Vitatex, Inc.
Market Segmentation & Coverage
This research report categorizes the Circulating Tumor Cell Market to forecast the revenues and analyze trends in each of the following sub-markets:
Specimen
Blood
Bone Marrow
Technology
CTC Analysis
CTC Detection & Enrichment Methods
Combined Methods
Density-Based Separation
Immunocapture
Negative Selection
Positive Selection
Size-Based Separation
Membrane-Based
Microfluidic-Based
CTC Direct Detection Methods
Microscopy
SERS
Product
Blood Collection Tubes
Devices or Systems
Kits & Reagents
Application
Clinical/ Liquid Biopsy
Risk Assessment
Screening & Monitoring
Research
Cancer Stem Cell & Tumorigenesis Research
Drug or Therapy Development
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Circulating Tumor Cell Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Circulating Tumor Cell Market?
3. What are the technology trends and regulatory frameworks in the Circulating Tumor Cell Market?
4. What is the market share of the leading vendors in the Circulating Tumor Cell Market?
5. Which modes and strategic moves are suitable for entering the Circulating Tumor Cell Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Circulating Tumor Cell Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increased spending in cancer-related therapies
- 5.1.1.2. Prevalence of cancer across the globe
- 5.1.1.3. Rising awareness and focus on early cancer detection
- 5.1.2. Restraints
- 5.1.2.1. Lack of awareness about CTC systems
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in bioengineering and biomedical practices
- 5.1.3.2. Demand for minimally invasive diagnostics in recent years
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations for the approval of CTC technologies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Circulating Tumor Cell Market, by Specimen
- 6.1. Introduction
- 6.2. Blood
- 6.3. Bone Marrow
- 7. Circulating Tumor Cell Market, by Technology
- 7.1. Introduction
- 7.2. CTC Analysis
- 7.3. CTC Detection & Enrichment Methods
- 7.4.1. Combined Methods
- 7.4.2. Density-Based Separation
- 7.4.3. Immunocapture
- 7.4.4.1. Negative Selection
- 7.4.4.2. Positive Selection
- 7.4.4. Size-Based Separation
- 7.4.5.1. Membrane-Based
- 7.4.5.2. Microfluidic-Based
- 7.4. CTC Direct Detection Methods
- 7.5.1. Microscopy
- 7.5.2. SERS
- 8. Circulating Tumor Cell Market, by Product
- 8.1. Introduction
- 8.2. Blood Collection Tubes
- 8.3. Devices or Systems
- 8.4. Kits & Reagents
- 9. Circulating Tumor Cell Market, by Application
- 9.1. Introduction
- 9.2. Clinical/ Liquid Biopsy
- 9.3.1. Risk Assessment
- 9.3.2. Screening & Monitoring
- 9.3. Research
- 9.4.1. Cancer Stem Cell & Tumorigenesis Research
- 9.4.2. Drug or Therapy Development
- 10. Americas Circulating Tumor Cell Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Circulating Tumor Cell Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Circulating Tumor Cell Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. BioFluidica
- 14.1.2. Biolidics Limited
- 14.1.3. Creatv MicroTech, Inc.
- 14.1.4. Epic Sciences
- 14.1.5. Fluxion Biosciences, Inc.
- 14.1.6. Greiner Bio One International GmbH
- 14.1.7. Ikonisys Inc.
- 14.1.8. IVDiagnostics
- 14.1.9. LungLife AI, Inc.
- 14.1.10. Menarini Silicon Biosystems
- 14.1.11. Miltenyi Biotec GmbH
- 14.1.12. NanoString Technologies, Inc.
- 14.1.13. Precision Medicine Group, LLC
- 14.1.14. QIAGEN GmbH
- 14.1.15. Rarecells Diagnostics
- 14.1.16. ScreenCell
- 14.1.17. STEMCELL Technologies, Inc.
- 14.1.18. Sysmex Corporation
- 14.1.19. Vitatex, Inc
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. CIRCULATING TUMOR CELL MARKET RESEARCH PROCESS
- FIGURE 2. CIRCULATING TUMOR CELL MARKET SIZE, 2023 VS 2030
- FIGURE 3. CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CIRCULATING TUMOR CELL MARKET DYNAMICS
- FIGURE 7. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2023 VS 2030 (%)
- FIGURE 8. CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 10. CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 12. CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.